Hydroxychloroquine [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2015-05-06 15:18 (3567 d 04:01 ago) – Posting: # 14760
Views: 13,945

Hi John(s),

❝ I'm looking for the inter-subject variability of the Cmax of oral hydroxychloroquine.


I guess you mean CVtotal? CVinter is only accessible in a crossover study. BE studies of hydroxy­chloro­quine are performed in a parallel design due to its long half-life.
In the future please :google: first.
If the CV was not given, I calculated it from the CIs and sample sizes:

Ref.  n   PK metric   PE      90% CI     CVtotal
 1   72   Cmax        97.1%  86.4–109.2%  29.8%
          AUClast*    94.3%  84.2–105.7%  29.0%
 2   72   Cmax        90.8%  79.3–104%    35.6%
          AUC0-72     99.5%  87.4–113%    33.6%
 3   54   Cmax        99.3%  98.1–102.1%   4.4%
          AUC0-24     99.7%  98.9–101.4%   2.7%


Liu’s CVs are simply bizarre. Unbelievable that such a paper passed the peer-review.


  1. Midha KK, Rawson MJ, Hubbard JW. Bioequivalence: Issues and Options. J Pharmacokin Biopharm. 1997;25(6):743–52.
  2. MHRA. Public Assessment Report: Hydroxychloroquine Sulphate 200mg Film-Coated Tablets. PL 17907/0017 (2007)
    online
  3. Liu YM et al. A Parallel Design Study to Assess the Bioequivalence of Generic and Branded Hydroxychloroquine Sulfate Tablets in Healthy Volunteers. Arzneim Forsch / Drug Res. 2012;62(12):644–9. doi:10.1055/s-0032-1329962.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
157 visitors (0 registered, 157 guests [including 13 identified bots]).
Forum time: 18:20 CET (Europe/Vienna)

There are sadistic scientists who hurry to hunt down errors
instead of establishing the truth.    Marie Curie

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5